BiotechTube
Alphalyse

Alphalyse

Odense, Denmark· Est.
alphalyse.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $500K

Overview

Founded in 2000, Alphalyse has established itself as a specialized service provider in the proteomics and biologics analytics space, focusing on high-quality, GMP-compliant mass spectrometry services. The company's core offering is the identification and quantification of host cell proteins and other process-related impurities, a critical need for biopharmaceutical developers. With over 20 years of experience and more than 750 completed MS-based HCP projects, it serves a global clientele of biotech firms, CMOs, and pharmaceutical companies. Its business model is purely service-based, providing expert analytical support without developing its own therapeutic pipeline.

ProteomicsDiagnostics

Technology Platform

Liquid chromatography-mass spectrometry (LC-MS) for protein identification and quantification, specializing in host cell protein (HCP) analysis and biologics characterization under GMP conditions.

Funding History

1
Total raised:$500K
Grant$500K

Opportunities

The rapid growth and increasing complexity of the biologics and advanced therapy markets create sustained demand for sophisticated impurity analysis.
Regulatory push for detailed characterization favors mass spectrometry over traditional methods, positioning Alphalyse's core technology as the future standard.
The company can leverage its vast project database ('HCPedia') to develop predictive tools and standardized assays, creating new service offerings.

Risk Factors

Competition from large, diversified CROs and potential in-house capabilities at large pharma clients.
Dependence on biotech/pharma R&D spending, which is cyclical and sensitive to economic downturns.
Technological disruption from new analytical methods and the continuous need for costly capital investment to maintain a leading-edge LC-MS platform.

Competitive Landscape

Alphalyse competes in the analytical services segment of the CRO market. It faces competition from large global CROs (e.g., Charles River, Labcorp, Eurofins) with broad service portfolios and from other specialized proteomics service labs. Its key differentiator is deep, niche expertise in GMP-compliant, MS-based HCP analysis, a reputation built over 20+ years and 750+ projects.

More companies in Proteomics & Protein Engineering →More companies in Denmark →